These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 21046454)
1. Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors. Portela-Gomes GM; Grimelius L; Stridsberg M Cell Mol Neurobiol; 2010 Nov; 30(8):1147-53. PubMed ID: 21046454 [TBL] [Abstract][Full Text] [Related]
2. Granins and granin-related peptides in neuroendocrine tumours. Portela-Gomes GM; Grimelius L; Wilander E; Stridsberg M Regul Pept; 2010 Nov; 165(1):12-20. PubMed ID: 20211659 [TBL] [Abstract][Full Text] [Related]
3. Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours. Stridsberg M; Eriksson B; Janson ET Regul Pept; 2008 Jun; 148(1-3):95-8. PubMed ID: 18448176 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining of human islet cells with region-specific antibodies against secretogranins II and III. Stridsberg M; Grimelius L; Portela-Gomes GM J Anat; 2008 Mar; 212(3):229-34. PubMed ID: 18221483 [TBL] [Abstract][Full Text] [Related]
5. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II. Portela-Gomes GM; Grimelius L; Stridsberg M Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951 [TBL] [Abstract][Full Text] [Related]
6. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Feldman SA; Eiden LE Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559 [TBL] [Abstract][Full Text] [Related]
7. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity. Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857 [TBL] [Abstract][Full Text] [Related]
8. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies. Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318 [TBL] [Abstract][Full Text] [Related]
9. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694 [TBL] [Abstract][Full Text] [Related]
10. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Helle KB Biol Rev Camb Philos Soc; 2004 Nov; 79(4):769-94. PubMed ID: 15682870 [TBL] [Abstract][Full Text] [Related]
11. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies. Portel-Gomes GM; Grimelius L; Johansson H; Wilander E; Stridsberg M Am J Surg Pathol; 2001 Oct; 25(10):1261-7. PubMed ID: 11688460 [TBL] [Abstract][Full Text] [Related]
12. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024 [TBL] [Abstract][Full Text] [Related]
13. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors. Conlon JM Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574 [TBL] [Abstract][Full Text] [Related]
14. Region-specific antibodies to chromogranin B display various immunostaining patterns in human endocrine pancreas. Portela-Gomes GM; Stridsberg M J Histochem Cytochem; 2002 Aug; 50(8):1023-30. PubMed ID: 12133905 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of chromogranins and secretogranins correlate with the progress and severity of Parkinson's disease. Xu DJ; Wei LY; Li HF; Zhang WQ Kaohsiung J Med Sci; 2019 Mar; 35(3):146-150. PubMed ID: 30887724 [TBL] [Abstract][Full Text] [Related]
16. Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas. Gomi H; Nagumo T; Asano K; Konosu M; Yasui T; Torii S; Hosaka M J Histochem Cytochem; 2022 May; 70(5):335-356. PubMed ID: 35400231 [TBL] [Abstract][Full Text] [Related]
17. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma. Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356 [TBL] [Abstract][Full Text] [Related]
18. Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms. Shulman RJ; Öhman L; Stridsberg M; Cain K; Simrén M; Heitkemper M Neurogastroenterol Motil; 2019 Jan; 31(1):e13486. PubMed ID: 30298961 [TBL] [Abstract][Full Text] [Related]
19. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy. Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942 [TBL] [Abstract][Full Text] [Related]
20. Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Montero-Hadjadje M; Vaingankar S; Elias S; Tostivint H; Mahata SK; Anouar Y Acta Physiol (Oxf); 2008 Feb; 192(2):309-24. PubMed ID: 18005393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]